Skip to main content
Caplight Logo









QUE Oncology

QUE Oncology

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.queoncology.com/

Last Round

Series A

Jun 5, 2017

Total Funding Raised

$16M

Company Overview

QUE Oncology is a biotechnology company that develops non-hormonal therapies for the treatment of vasomotor symptoms in cancer patients and postmenopausal women.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologyclinical trialssmall-molecule therapeuticsdrug developmenthot flashesbreast cancer treatmentnon-hormonal therapybiotech startupdrug discoverytherapeutic candidatesupportive careclinical-stage biotechpharma licensingcancer side effects

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QUE Oncology Comparables

Compare QUE Oncology with similar companies based on industry and business-model similarity.

QUE Oncology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fervent Pharmaceuticals
86%
Tioga Pharmaceuticals
80%
MenoGeniX, Inc.
79%

QUE Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 5, 2017

QUE Oncology Investors

Notable investors and investment history

QUE Oncology investors
InvestorRounds
UniQuest Pty LtdSeed
Emory UniversitySeed
Georgia Research AllianceSeed
UniseedSeries A
Brandon CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2017

    $16M round led by Brandon Capital.

QUE Oncology Filings

Explore SEC and related filing metadata, where available.

QUE Oncology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QUE Oncology's valuation, stock price, and market status.

Is QUE Oncology a public or private company?

QUE Oncology is a private company.

What is the current stock price of QUE Oncology?

QUE Oncology is a private company with no public stock price. Caplight tracks QUE Oncology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is QUE Oncology worth (valuation)?

Valuation information for QUE Oncology is not publicly available.

Can I buy QUE Oncology stock?

QUE Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was QUE Oncology's last funding round?

QUE Oncology's most recent funding round was Series A on June 5, 2017.

Who are the main investors in QUE Oncology?

Key investors in QUE Oncology include Brandon Capital.

Will QUE Oncology IPO soon?

No public IPO plans have been announced for QUE Oncology.

How can I track QUE Oncology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QUE Oncology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range1
Year Founded2013
Last FundingJun 5, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?